Cargando…
Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation—A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation
Background: Optimal timing to initiate anticoagulation after acute ischemic stroke (AIS) from atrial fibrillation (AF) is currently unknown. Compared to other stroke etiologies, AF typically provokes larger infarct volumes and greater concern of hemorrhagic transformation, so seminal randomized tria...
Autores principales: | Rose, David Z., Meriwether, John N., Fradley, Michael G., Renati, Swetha, Martin, Ryan C., Kasprowicz, Thomas, Patel, Aarti, Mokin, Maxim, Murtagh, Ryan, Kip, Kevin, Bozeman, Andrea C., McTigue, Tara, Hilker, Nicholas, Kirby, Bonnie, Wick, Natasha, Tran, Nhi, Burgin, W. Scott, Labovitz, Arthur J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763567/ https://www.ncbi.nlm.nih.gov/pubmed/31620067 http://dx.doi.org/10.3389/fneur.2019.00975 |
Ejemplares similares
-
Middle Cerebral Artery Duplication: A Near Miss for Stroke Thrombectomy
por: Pressman, Elliot, et al.
Publicado: (2021) -
Untreated Stroke as Collateral Damage of COVID-19: “Time Is Brain” Versus “Stay at Home”
por: Rose, David Z., et al.
Publicado: (2020) -
Accidental Thrombolysis in a Stroke Patient Receiving Apixaban
por: Fluri, Felix, et al.
Publicado: (2015) -
Apixaban for Secondary Stroke Prevention: Coexistant Cerebral Atherosclerosis May Increase Recurrent Strokes
por: Kim, Jong S., et al.
Publicado: (2022) -
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
por: Kirchhof, Paulus, et al.
Publicado: (2018)